Literature DB >> 24274755

Biology and genetics of prions causing neurodegeneration.

Stanley B Prusiner1.   

Abstract

Prions are proteins that acquire alternative conformations that become self-propagating. Transformation of proteins into prions is generally accompanied by an increase in β-sheet structure and a propensity to aggregate into oligomers. Some prions are beneficial and perform cellular functions, whereas others cause neurodegeneration. In mammals, more than a dozen proteins that become prions have been identified, and a similar number has been found in fungi. In both mammals and fungi, variations in the prion conformation encipher the biological properties of distinct prion strains. Increasing evidence argues that prions cause many neurodegenerative diseases (NDs), including Alzheimer's, Parkinson's, Creutzfeldt-Jakob, and Lou Gehrig's diseases, as well as the tauopathies. The majority of NDs are sporadic, and 10% to 20% are inherited. The late onset of heritable NDs, like their sporadic counterparts, may reflect the stochastic nature of prion formation; the pathogenesis of such illnesses seems to require prion accumulation to exceed some critical threshold before neurological dysfunction manifests.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24274755      PMCID: PMC4010318          DOI: 10.1146/annurev-genet-110711-155524

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  196 in total

1.  Stress granule assembly is mediated by prion-like aggregation of TIA-1.

Authors:  Natalie Gilks; Nancy Kedersha; Maranatha Ayodele; Lily Shen; Georg Stoecklin; Laura M Dember; Paul Anderson
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

2.  Natural and synthetic prion structure from X-ray fiber diffraction.

Authors:  Holger Wille; Wen Bian; Michele McDonald; Amy Kendall; David W Colby; Lillian Bloch; Julian Ollesch; Alexander L Borovinskiy; Fred E Cohen; Stanley B Prusiner; Gerald Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

4.  Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery.

Authors:  C Bernoulli; J Siegfried; G Baumgartner; F Regli; T Rabinowicz; D C Gajdusek; C J Gibbs
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

5.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

6.  Generating a prion with bacterially expressed recombinant prion protein.

Authors:  Fei Wang; Xinhe Wang; Chong-Gang Yuan; Jiyan Ma
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

Review 7.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

8.  Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

9.  A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.

Authors:  Robert M Cohen; Kavon Rezai-Zadeh; Tara M Weitz; Altan Rentsendorj; David Gate; Inna Spivak; Yasmin Bholat; Vitaly Vasilevko; Charles G Glabe; Joshua J Breunig; Pasko Rakic; Hayk Davtyan; Michael G Agadjanyan; Vladimir Kepe; Jorge R Barrio; Serguei Bannykh; Christine A Szekely; Robert N Pechnick; Terrence Town
Journal:  J Neurosci       Date:  2013-04-10       Impact factor: 6.167

Review 10.  Prion-like spread of protein aggregates in neurodegeneration.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  J Exp Med       Date:  2012-05-07       Impact factor: 14.307

View more
  184 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  [PSI(+)] turns 50.

Authors:  Mick F Tuite; Gemma L Staniforth; Brian S Cox
Journal:  Prion       Date:  2015       Impact factor: 3.931

3.  Neurodegeneration: Amyloid-β pathology induced in humans.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

Review 4.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

5.  Prion-like nanofibrils of small molecules (PriSM) selectively inhibit cancer cells by impeding cytoskeleton dynamics.

Authors:  Yi Kuang; Marcus J C Long; Jie Zhou; Junfeng Shi; Yuan Gao; Chen Xu; Lizbeth Hedstrom; Bing Xu
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

6.  The SH3 domain of Fyn kinase interacts with and induces liquid-liquid phase separation of the low-complexity domain of hnRNPA2.

Authors:  Joshua Amaya; Veronica H Ryan; Nicolas L Fawzi
Journal:  J Biol Chem       Date:  2018-11-05       Impact factor: 5.157

Review 7.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 8.  A brief overview of the Swi1 prion-[SWI+].

Authors:  Dustin K Goncharoff; Zhiqiang Du; Liming Li
Journal:  FEMS Yeast Res       Date:  2018-09-01       Impact factor: 2.796

9.  PRNP/prion protein regulates the secretion of exosomes modulating CAV1/caveolin-1-suppressed autophagy.

Authors:  Marcos V S Dias; Bianca L Teixeira; Bruna R Rodrigues; Rita Sinigaglia-Coimbra; Isabel Porto-Carreiro; Martín Roffé; Glaucia N M Hajj; Vilma R Martins
Journal:  Autophagy       Date:  2016-09-14       Impact factor: 16.016

Review 10.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.